A new drug for pancreas cancer may be a game changer, Elizabeth Tracey reports
About this episode
A new drug called Daraxonrasib shows promise in extending survival for pancreas cancer patients, according to a recent clinical trial.
Daraxonrasib is the name of a drug to treat pancreas cancer that has extended survival in many with the disease, a just reported clinical trial finds.  Johns Hopkins Kimmel Cancer Center director William Nelson says it’s gotten many people who treat … A new drug for pancreas cancer may be a game changer, Elizabeth Tracey reports Read More »
More episodes of Health Newsfeed – Johns Hopkins Medicine Podcasts
- An AI model may help predict who is more likely to develop pancreas cancer, Elizabeth Tracey reports
- Will GLP1 drugs tease out the relationship between insulin and cancer? Elizabeth Tracey reports
- Is there a relationship between diet, obesity and colorectal cancer? Elizabeth Tracey reports
- What accounts for increases in colorectal cancer among younger people? Elizabeth Tracey reports
- A new drug for pancreas cancer may be a game changer, Elizabeth Tracey reports
- Certain groups of people seem to be missing out when it comes to optimizing cardiovascular disease prevention, Elizabeth Tracey reports
Explore listener stats, chart rankings, contacts and more on the Health Newsfeed – Johns Hopkins Medicine Podcasts podcast page.